Skip to main content
Premium Trial:

Request an Annual Quote

Split Biosciences Rebrands as Parse Biosciences, Raises $7M in Series A Financing

NEW YORK – Parse Biosciences, formerly known as Split Biosciences, announced Tuesday it has raised $7 million in Series A financing.

Bioeconomy Capital led the round, joined by new investors and existing angel investors. Parse will use the funds to scale the commercial roll-out of its whole-transcriptome assay kit for single-cell RNA sequencing.

"From the sheer scalability of their technology, to the entirely unique flexibility that their single-cell sequencing kits provides to researchers, Parse Biosciences is creating a new standard for the single cell market," Rob Carlson, managing director at Bioeconomy Capital, said in a statement. "We’re excited to back this emerging leader of the industry and support their continued expansion to serve labs all over the world."

Seattle-based Parse is a University of Washington spinout commercializing split-pool ligation-based transcriptome sequencing (SPLiT-seq), a single-cell RNA-seq method that chemically fixes and immobilizes cells instead of physically isolating them. In contrast to some popular droplet-based single-cell sequencing methods, SPLiT-seq does not require additional specialized instrumentation.

The new financing adds to approximately $1.2 million in seed financing raised by Split Bio in 2018.

"We have spent the last three years developing a product that more scientists could actually use," Parse Biosciences Cofounder and CTO Charlie Roco said in a statement. "Our kits are now operating at a higher level than anything else we’ve seen on the market and our company has evolved beyond our original SPLiT-seq method. We wanted our brand to reflect that."

Bioeconomy Capital provided seed funding to Bellwether Bio, another UW spinout, which was acquired by Guardant Health in 2019.

The Scan

Close Panel Vote on Califf Nomination

The New York Times reports there was a close committee vote to advance the nomination of Robert Califf to lead the US Food and Drug Administration to the full Senate.

Task Force Reports on Scientific Integrity

Nature News writes that that a new task force report recommends that the US establish a cross-agency scientific integrity council.

Across the Hall

Genetic testing, closed-circuit cameras, and more show how a traveler, without any contact, infected others at a New Zealand quarantine facility, CNN reports.

Science Paper Examines Influence of Chromatin Modifications on Obsessive-Compulsive Disorder

In Science this week: genes regulating chromatin modification may contribute to OCD risk.